Prognosis in the Elderly Chinese: the Northern Shanghai Study

Cardiovascular Risk Factor Clinical Trial

— NSS  

Official title:

Prognosis Factors of Mortality and Cardiovascular Diseases in the Elderly Chinese: the Northern Shanghai Study

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT02368938
• Other study ID #: NSS
• Status: Enrolling by invitation
• Phase: N/A
• First received: February 15, 2015
• Last updated: February 20, 2015
• Start date: August 2014

Study information

• Verified date: February 2015
• Source: Shanghai 10th People's Hospital
• Contact: n/a
• Is FDA regulated: No
• Health authority: China: Food and Drug Administration
• Study type: Observational

Clinical Trial Summary

The Northern Shanghai Study is a prospective community-based study, which is aimed to investigate the prognostic factors, including conventional cardiovascular risk factors and asymptomatic target organ damage, for mortality and cardiovascular diseases, in 5,000 elderly Chinese.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 5000
• Est. primary completion date: September 2017
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 65 Years and older

Eligibility

Inclusion Criteria:

1. age=65 years old(depending on identity card);

2. informed consent should be signed voluntarily;

3. the individuals are long-term residents in northern Shanghai.

Exclusion Criteria:

1. is diagnosed serious heart disease (NYHA>IV) or end stage renal disease (CKD > 4);

2. suffered with cancer and life expectancy was less than 5 years;

3. has stroke within 3 months;

4. is not willing to participate in the clinical study;

5. suffered with other disease to quite the trial;

6. violated the protocol;

7. lost contact with laboratory staff.

Study Design

Observational Model: Ecologic or Community, Time Perspective: Prospective

Related Conditions & MeSH terms

• Cardiovascular Risk Factor

Locations

Country	Name	City	State
n/a

Sponsors (1)

Lead Sponsor	Collaborator
Shanghai 10th People's Hospital

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	all-cause and cardiovascular mortality, cardiovascular events		one year	No
Primary	Cardiovascular diseases		one year	No